Related Experiment Video
Updated: Jun 6, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Antiviral therapy and hidden predictors of postoperative outcomes in hepatocellular carcinoma
Nadeem Ashraf1, Qingyong Hong1, Zhidong Guo1
1Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, No. 169, Donghu Road, Wuchang District, Wuhan, 430061, China.
Background:
Hepatocellular carcinoma (HCC) is a global health burden and hepatitis B virus (HBV) infection is a common cause. Antiviral therapy has the possibility to reduce the incidence of HCC, and recurrence of HCC after surgical resection.
Methods:
A total of 410 HCC patients had hepatectomy at Zhongnan hospital of Wuhan University. Categorization of these patients was done on the basis of HBV antiviral therapy. Recurrence-free survival (RFS) and the overall survival (OS) rates were assessed during follow-up period. Tumor necrosis percentage, recovery of liver functions, and tumor-related characteristics were also examined in these patients. Statistical analyses were conducted using Kaplan-Meier survival curves and Cox regression models.
Results:
After applying strict selection criteria, only 93 patients formed the observation group. These patients had comparatively smaller tumor size ≤5 cm(76.3% vs. 45.1%) and less tumor necrosis (30.1% vs. 54.6%). OS (p = 0.035) and RFS (p = 0.034) was also improved in the observation group. However, antiviral therapy did not show any significant effect on OS (p = 0.188) and RFS (p = 0.527) after a multivariate adjustment. Microvascular invasion of more than 5 foci (OS HR = 2.96; RFS HR = 1.97), poor differentiation (RFS HR = 2.70), and stage C versus 0 of BCLC (OS HR = 3.75; RFS HR = 4.40) were independent adverse prognostic factors. Kaplan-Meier analysis indicated that tumour necrosis was associated with overall survival (OS) and recurrence-free survival (RFS), and this finding was validated in sensitivity analyses.
Conclusion:
While antiviral therapy correlated with improved tumor pathology and univariate survival outcomes, it was not an independent prognostic factor after adjustment. Tumor necrosis independently predicted worse OS and RFS. Prognosis was primarily driven by microvascular invasion, poor differentiation, and advanced BCLC stage, suggesting antiviral benefits may operate indirectly through tumor biology modulation.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Retrovirus Life Cycles
Antiviral Nucleoside Inhibitors
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
